This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Biotechnology Remove Integration Remove Life Sciences Remove Regulations
article thumbnail

ChristianaCare Spins Out New Gene Editing Company, CorriXR Therapeutics

HIT Consultant

OCTOBER 13, 2022

What You Should Know: – ChristianaCare recently announced it has spun out its first commercial biotechnology private startup company, named CorriXR Therapeutics. The CorriXR Therapeutics team includes experienced biotechnology executives and world-renowned scientists and clinicians. The executive team is led by Eric Kmiec, Ph.D.,

Biotechnology 98
Biotechnology Regulations Prevention Integration 98
article thumbnail

Athos Therapeutics Taps Vultr Cloud GPU to Power AI Drug Discovery Engine

HIT Consultant

JUNE 19, 2024

Athos”), a clinical-stage biotechnology company, has chosen Vultr Cloud GPU to run its AI model training, tuning, and inference. This choice ensures compliance with data sovereignty and privacy regulations, crucial for handling sensitive AI training data.

Biotechnology 111
Biotechnology Regulations Integration Hospitals 111
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 19,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024